Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BioPhausia AB
AB
Dissolved
Org 5564850153
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1994 · 32 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
BioPhausia AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
268M
201M
134M
67M
0M
2017: 202M
202M
2017
2018: 213M (+5% vs 2017)
213M
+5%
2018
2019: 215M (+1% vs 2018)
215M
+1%
2019
2020: 171M (-20% vs 2019)
171M
-20%
2020
2021: 147M (-14% vs 2020)
147M
-14%
2021
EBITDA
SEK millions
171M
128M
85M
43M
0M
2017: 117M
117M
2017
2018: 137M (+17% vs 2017)
137M
+17%
2018
2019: 134M (-2% vs 2018)
134M
-2%
2019
2020: 108M (-19% vs 2019)
108M
-19%
2020
2021: 91M (-16% vs 2020)
91M
-16%
2021
Income statement
SEK thousands
Item
2021
2020
2019
2018
2017
Revenue
147 409
171 356
215 412
213 050
202 438
Staff expenses
—
—
—
—
—
EBITDA
90 760
108 009
133 885
137 174
116 918
Depreciation & amort.
−289
−0
−16
−16 219
−32 380
EBIT
90 471
108 009
133 869
120 955
84 538
Net financials
−339
−531
1 195
−301
−511
Profit before tax
−674
−682
−458
68 251
42 915
Tax
−10
−0
−0
−15 030
−9 444
Net profit
−684
−682
−458
53 221
33 471
Balance sheet
SEK thousands
Item
2021
2020
2019
2018
2017
Total assets
277 807
282 927
345 779
254 907
200 776
Equity
149 725
150 408
151 091
151 548
98 327
Long-term debt
0
0
0
0
0
Short-term debt
128 082
122 037
184 207
80 546
86 282
Total debt
128 082
122 037
184 207
80 546
86 282
Financial ratios
5-year trend
EBITDA margin
61,6 %
This company
15,8 %
Market median
This company
Market median
290% above market
2017
2021
Equity ratio
53,9 %
This company
38,2 %
Market median
This company
Market median
41% above market
2017
2021
Return on equity
−0,5 %
This company
18,4 %
Market median
This company
Market median
103% below market
2017
2021
Net profit margin
−0,5 %
This company
8,1 %
Market median
This company
Market median
106% below market
2017
2021
Asset turnover
0,53×
This company
1,12×
Market median
This company
Market median
53% below market
2017
2021
Debt / equity
0,86×
This company
0,62×
Market median
This company
Market median
39% above market
2017
2021
Annual reports & filings
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
More on BioPhausia AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
